Evidence map›Paper›PMID 40329173›Full record

ArticleBMC genomics2025

Evolutionary responses of Escherichia coli to phage pressure: insights into mucoidy and colanic acid overexpression.

Laurie C Piché, Sophie Bories, Viacheslav Liato, Valérie E Paquet, Linda Saucier, Marie-Pierre Létourneau-Montminy, Steve J Charette, Rodrigue Dubar, Simon J Labrie, Patrick Lagüe and 1 more

Abstract read
In one paragraph

Article in BMC genomics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Laurie C PichéInstitut de biologie intégrative et des systèmes (IBIS), Université Laval, Quebec City, QC, G1V 0A6, Canada.
Sophie BoriesInstitut de biologie intégrative et des systèmes (IBIS), Université Laval, Quebec City, QC, G1V 0A6, Canada.
Viacheslav LiatoSyntBioLab Inc. Lévis, Quebec, G6W 0L9, Canada.
Valérie E PaquetInstitut de biologie intégrative et des systèmes (IBIS), Université Laval, Quebec City, QC, G1V 0A6, Canada.
Linda SaucierDépartement des sciences animales, Faculté des sciences de l'agriculture et de l'alimentation, Université Laval, Pavillon Paul-Comtois, 2425 Rue de L'Agriculture, Quebec City, QC, G1V 0A6, Canada.
Marie-Pierre Létourneau-MontminyDépartement des sciences animales, Faculté des sciences de l'agriculture et de l'alimentation, Université Laval, Pavillon Paul-Comtois, 2425 Rue de L'Agriculture, Quebec City, QC, G1V 0A6, Canada.
Steve J CharetteInstitut de biologie intégrative et des systèmes (IBIS), Université Laval, Quebec City, QC, G1V 0A6, Canada.
Rodrigue DubarSyntBioLab Inc. Lévis, Quebec, G6W 0L9, Canada.
Simon J LabrieSyntBioLab Inc. Lévis, Quebec, G6W 0L9, Canada.
Patrick LagüeInstitut de biologie intégrative et des systèmes (IBIS), Université Laval, Quebec City, QC, G1V 0A6, Canada.
Antony T VincentInstitut de biologie intégrative et des systèmes (IBIS), Université Laval, Quebec City, QC, G1V 0A6, Canada. antony.vincent@fsaa.ulaval.ca.

Funding

MAPAQ (Innov'Action) IA120638Natural Sciences and Engineering Research Council of Canada RGPIN-2022-03321
6 · The paper itself

Abstract

backgroundAntibiotic resistance is a major issue affecting all spheres of human activity, including agriculture. One significant example is the Avian Pathogenic Escherichia coli (APEC), a bacterium that infects poultry and leads to substantial economic losses in the farming industry. As antibiotics lose efficacity, bacteriophages (phages) -viruses that specifically target bacteria-are emerging as a promising alternative to antibiotics for treating and preventing bacterial infections. However, bacteria can develop resistance to phages through various mechanisms. Studying the coevolution between a phage and its host bacterium is important to gain insight into the phage's potential as a therapeutic agent. This study investigates the evolutionary responses of an APEC strain and a laboratory E. coli strain to a commercial phage originally isolated from APEC.

resultsIn most cases, phage resistance resulted in a significant increase in mucoidy. Genomic analysis revealed that this resistance consistently correlated with amino acid changes, particularly in proteins involved in colanic acid production, such as YrfF. Further investigation of a mutation found in the YrfF protein demonstrated that this mutation altered the protein's structure and its interaction with the membrane. Transcriptomic analysis confirmed that the genes involved in colanic acid production were significantly overexpressed. Although the strains possessed a CRISPR-Cas system, it did not contribute to phage resistance.

conclusionsThis study suggests that specific amino acid changes in key proteins may be a mechanism employed by E. coli, including APEC, to defend against phage infections.

Indexed as

BacteriophagesColiphagesEscherichia coliEvolution, MolecularEscherichia coli ProteinsMutationPolysaccharidescolanic acidEscherichia coli ProteinsPolysaccharidesAPECBacteriophageColanic acidE. coliMucoidyPhage resistanceyrfF

Identifiers

PMID40329173
PMCPMC12057083

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.